Always up to date.

Merz Therapeutics announces today the appointment of Leonard Paolillo as President, Merz Therapeutics North America, effective immediately. In this role, Leonard will join the Global Therapeutics...

Acquisition of INBRIJA (levodopa inhalation powder) and (F)AMPYRA (fampridine) expands specialty neurology portfolio. Lays groundwork for Parkinson’s disease franchise and anchor in multiple...

Merz Therapeutics, a business of the Merz Group and a leader in the field of neurotoxins, received approval from Swissmedic, the national authorization and supervisory authority for drugs and medical...

Merz Therapeutics, a business of the Merz Group and leader in the field of neurotoxins, announces the promotion of Dr. Michael Pfeil to the role of Head of Therapeutics Operations, effective January...

Ten of the Merz Therapeutics subsidiaries' participating countries received esteemed employer certifications.

Merz Therapeutics, a business of the Merz Group and leader in the field of neurotoxins, has received approval from the Therapeutic Goods Administration (TGA) in Australia for the use of...

Merz Therapeutics, a business of the Merz Group and a leader in the field of neurotoxins, is pleased to announce the appointment of Mark Altmeyer as a Non-Executive Director, with effect from 01...

Merz Therapeutics, a business of the Merz Group and a leader in the field of neurotoxins, kicked off its first “Merz Expert Connect Summit” today. The event focuses on advanced treatment options for...

Merz Therapeutics expands its operations to Sweden, Norway and Denmark by establishing its own affiliate in the Nordics. In this interview, Stefan König, CEO of Merz Therapeutics, and Christian...

Merz Therapeutics, a company of the Merz Group and a leader in the field of neurotoxins, celebrates the opening of its new affiliate in Stockholm for the Nordic region including Denmark, Sweden, and...

Dive into an inspiring conversation with Kevin Walker, head of the LGBTQIA+ advocacy group at Merz Therapeutics in North America. Explore his personal journey and impactful initiatives fostering...

Merz Therapeutics, received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom

Mexico City, London, and now Frankfurt am Main, Germany: Experienced Pharma manager appointed to lead Merz Therapeutics

Merz Therapeutics, a company of the Merz Group and a leader in the field of neurotoxins, is expanding its strategic partnership with Vensica Therapeutics

Today, Merz Therapeutics, a business of the Merz Group and a leader in the field of neurotoxins,...

Merz Therapeutics, a business of the Merz Group and a leader in the field of neurotoxins, and the Israeli start-up Vensica Therapeutics Ltd.,...

Merz Therapeutics, as part of the Merz Group and a leader in the field of neurotoxins,...

Merz Therapeutics GmbH, a leading neurotoxin company and subsidiary of Merz Pharma GmbH & Co. KGaA,...

Merz, a global leader in neurotoxin therapy, announced today the European approval of XEOMIN^® (incobotulinumtoxinA)...

Merz, a global leader in aesthetics and neurotoxins, and Teijin Limited, a technology-driven global group operating...